BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11249756)

  • 1. Herpesvirus vectors come of age.
    Hammerschmidt W
    Curr Opin Mol Ther; 2000 Oct; 2(5):532-9. PubMed ID: 11249756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral gene therapy strategies: from basic science to clinical application.
    Young LS; Searle PF; Onion D; Mautner V
    J Pathol; 2006 Jan; 208(2):299-318. PubMed ID: 16362990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retroviral vectors for gene therapy of AIDS and cancer.
    Chang LJ; He J
    Curr Opin Mol Ther; 2001 Oct; 3(5):468-75. PubMed ID: 11699891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in retrovirus vector-mediated gene therapy: teaching an old vector new tricks.
    Weber E; Anderson WF; Kasahara N
    Curr Opin Mol Ther; 2001 Oct; 3(5):439-53. PubMed ID: 11699888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpesvirus saimiri.
    Fickenscher H; Fleckenstein B
    Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):545-67. PubMed ID: 11313011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The leukemogenic risk of integrating retroviral vectors in hematopoietic stem cell gene therapy applications.
    Kang EM; Tisdale JF
    Curr Hematol Rep; 2004 Jul; 3(4):274-81. PubMed ID: 15217557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and application of replication-incompetent HSV-1-based vectors.
    Berto E; Bozac A; Marconi P
    Gene Ther; 2005 Oct; 12 Suppl 1():S98-102. PubMed ID: 16231061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biosafety of herpesvirus vectors.
    Gogev S; Schynts F; Meurens F; Bourgot I; Thiry E
    Curr Gene Ther; 2003 Dec; 3(6):597-611. PubMed ID: 14683454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vectors and delivery systems in gene therapy.
    Gardlík R; Pálffy R; Hodosy J; Lukács J; Turna J; Celec P
    Med Sci Monit; 2005 Apr; 11(4):RA110-21. PubMed ID: 15795707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biology and application of herpesviruses for gene therapy].
    Kondo K
    Tanpakushitsu Kakusan Koso; 2007 Aug; 52(10 Suppl):1294-300. PubMed ID: 17824255
    [No Abstract]   [Full Text] [Related]  

  • 11. Intraarterial delivery of genetic vectors for the treatment of malignant brain tumors.
    Cohen ZR; Duvdevani R; Nass D; Hadani M; Ram Z
    Isr Med Assoc J; 2001 Feb; 3(2):117-20. PubMed ID: 11344821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of gene therapy for hematopoietic stem cell using viral vectors].
    Dong WJ; Zu ZX; Liu DP; Liang CC
    Yi Chuan Xue Bao; 2003 Apr; 30(4):382-8. PubMed ID: 12812066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection control for gene therapy: a busy physician's primer.
    Evans ME; Lesnaw JA
    Clin Infect Dis; 2002 Sep; 35(5):597-605. PubMed ID: 12173136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolytic herpes simplex virus vectors for cancer virotherapy.
    Varghese S; Rabkin SD
    Cancer Gene Ther; 2002 Dec; 9(12):967-78. PubMed ID: 12522436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-viral and viral vectors for gene therapy.
    Boulaiz H; Marchal JA; Prados J; Melguizo C; Aránega A
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(1):3-22. PubMed ID: 16171561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in developing cationic vectors for non-viral systemic gene therapy against cancer.
    Morille M; Passirani C; Vonarbourg A; Clavreul A; Benoit JP
    Biomaterials; 2008; 29(24-25):3477-96. PubMed ID: 18499247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alphavirus vectors for cancer gene therapy (review).
    Yamanaka R
    Int J Oncol; 2004 Apr; 24(4):919-23. PubMed ID: 15010830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncolytic viruses for the treatment of cancer: current strategies and clinical trials.
    Ries SJ; Brandts CH
    Drug Discov Today; 2004 Sep; 9(17):759-68. PubMed ID: 15450242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replication-selective oncolytic viruses in the treatment of cancer.
    Everts B; van der Poel HG
    Cancer Gene Ther; 2005 Feb; 12(2):141-61. PubMed ID: 15472714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.
    Qiao J; Moreno J; Sanchez-Perez L; Kottke T; Thompson J; Caruso M; Diaz RM; Vile R
    Gene Ther; 2006 Oct; 13(20):1457-70. PubMed ID: 16724095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.